84
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Histological study of the biodynamics of iron oxide nanoparticles with different diameters

, , , , , , , , , & show all
Pages 1587-1594 | Published online: 02 Aug 2011

References

  • SainiSStarkDDHahnPFWittenbergJFerrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial systemRadiology19871621 Pt 12112163786765
  • WeisslederRStarkDDEngelstadBLSuperparamagnetic iron oxide: pharmacokinetics and toxicityAJR Am J Roentgenol198915211671732783272
  • WeisslederRElizondoGWittenbergJUltrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imagingRadiology199017524944982326475
  • WillOPurkayasthaSChanCDiagnostic precision of nanoparticle- enhanced MRI for lymph-node metastases: a meta- analysisLancet Oncol200671526016389184
  • SigalRVoglTCasselmanJLymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR): results of a phase-III multicenter clinical trialEur Radiol20021251104111311976854
  • DaldrupHELinkTMBlasiusSMonitoring radiation-induced changes in bone marrow histopathology with ultra-small superparamagnetic iron oxide (USPIO)-enhanced MRIJ Magn Reson Imaging19999564365210331759
  • SenéterreEWeisslederRJaramilloDBone marrow: ultrasmall superparamagnetic iron oxide for MR imagingRadiology199117925295332014305
  • HarisinghaniMGSainiSWeisslederRSplenic imaging with ultrasmall superparamagnetic iron oxide ferumoxtran-10 (AMI-7227): preliminary observationsJ Comput Assist Tomogr200125577077611584239
  • WeisslederRHahnPFStarkDDSuperparamagnetic iron oxide: enhanced detection of focal splenic tumors with MR imagingRadiology198816923994033174987
  • StarkDDWeisslederRElizondoGSuperparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liverRadiology198816822973013393649
  • WeisslederRElizondoGWittenbergJUltrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imagingRadiology199017524894932326474
  • VassalloPMateiCHestonWDAMI-227-enhanced MR lymphography: usefulness for differentiating reactive from tumor-bearing lymph nodesRadiology11199419325015067972768
  • AnzaiYPrinceMRChenevertTLMR angiography with an ultrasmall superparamagnetic iron oxide blood pool agentJ Magn Reson Imaging1997712092149039617
  • LoubeyrePZhaoSCanetEUltrasmall superparamagnetic iron oxide particles (AMI 227) as a blood pool contrast agent for MR angiography: experimental study in rabbitsJ Magn Reson Imaging1997769589629400837
  • RenkinEMMultiple pathways of capillary permeabilityCirc Res1977416735743923024
  • BanerjeeSNarayananKMizutaniTMurine coronavirus replication-induced p38 mitogen-activated protein kinase activation promotes interleukin-6 production and virus replication in cultured cellsJ Virol200276125937594812021326
  • KhouryMEscriouVCourtiesGEfficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexesArthritis Rheum20085882356236718668557
  • TaniguchiSYanaseTKobayashiKDehydroepiandrosterone markedly inhibits the accumulation of cholesteryl ester in mouse macrophage J774-771 cellsAtherosclerosis199612611431548879442
  • JoJAokiITabataYDesign of iron oxide nanoparticles with different sizes and surface charges for simple and efficient labeling of mesenchymal stem cellsJ Control Release2010142346547319932720
  • SharmaRSainiSRosPRSafety profile of ultrasmall superparamagnetic iron oxide ferumoxtran-10: phase II clinical trial dataJ Magn Reson Imaging19999229129410077027
  • McLachlanSJMorrisMRLucasMAPhase I clinical evaluation of a new iron oxide MR contrast agentJ Magn Reson Imaging1994433013078061425
  • HilfikerPRDebatinJFTarloKAssessment of peritoneal tolerance of a new MR blood pool contrast agent in rabbitsInvest Radiol1999341172272710548385
  • ReddyDKMooreHLLeeJHChronic peritoneal dialysis in iron-deficient rats with solutions containing iron dextranKidney Int200159276477311168960
  • BastaniBGalleySIntraperitoneal iron-dextran as a potential route of iron therapy in CAPD patientsPerit Dial Int19961666466488981540
  • LukasGBrindleSDGreengardPThe route of absorption of intraperitoneally administered compoundsJ Pharmacol Exp Ther197117835625645571904
  • RusznyákLFöldiMSzaboGFiltration and absorption through serous membranesLymphatics and Lymph Circulation2nd edOxfordPergamon Press1967478497
  • TilneyNLPatterns of lymphatic drainage in the adult laboratory ratJ Anat1971109Pt 33693835153800
  • ZylberbergBDormontDAntoineJMFirst line immunochemotherapy with cisplatin-based protocol by intraperitoneal and intravenous routes in ovarian cancer: technique and results of 82 casesEur J Obstet Gynecol Reprod Biol199666157648735760
  • RufPKlugeMJägerMPharmacokinetics, immunogenicity and bioactivity of the therapeutic antibody catumaxomab intraperitoneally administered to cancer patientsBr J Clin Pharmacol201069661762520565453
  • TamanoMHashimotoTKojimaKDiagnosis of hepatic hydrothorax using contrast-enhanced ultrasonography with intraperitoneal injection of SonazoidJ Gastroenterol Hepatol201025238338619817961